These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 16980074)
41. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines. Tamimoto Y; Horiuchi T; Tsukamoto H; Otsuka J; Mitoma H; Kimoto Y; Nakashima H; Muta K; Abe Y; Kiyohara C; Ueda A; Nagasawa K; Yoshizawa S; Shimoda T; Harada M Rheumatology (Oxford); 2008 Jun; 47(6):821-7. PubMed ID: 18397955 [TBL] [Abstract][Full Text] [Related]
42. [Efficacy of rituximab in a case of refractory bullous pemphigoid]. Reguiaï Z; Tchen T; Perceau G; Bernard P Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800 [TBL] [Abstract][Full Text] [Related]
43. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Roccatello D; Fornasieri A; Giachino O; Rossi D; Beltrame A; Banfi G; Confalonieri R; Tarantino A; Pasquali S; Amoroso A; Savoldi S; Colombo V; Manno C; Ponzetto A; Moriconi L; Pani A; Rustichelli R; Di Belgiojoso GB; Comotti C; Quarenghi MI Am J Kidney Dis; 2007 Jan; 49(1):69-82. PubMed ID: 17185147 [TBL] [Abstract][Full Text] [Related]
44. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660 [TBL] [Abstract][Full Text] [Related]
45. Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome. Silvana B; Antonella LM; Basilia P; Trombetta D; Saija A; Salpietro C Pediatr Transplant; 2007 Aug; 11(5):552-6. PubMed ID: 17631027 [TBL] [Abstract][Full Text] [Related]
46. Membranoproliferative glomerulonephritis due to Hepatitis C in renal allograft. Al-Arrayed AS; George SM; Ratnakar KS Saudi Med J; 2002 Jun; 23(6):743-5. PubMed ID: 12070561 [TBL] [Abstract][Full Text] [Related]
47. A novel approach to successful ABO-incompatible high-titer renal transplantation. Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213 [TBL] [Abstract][Full Text] [Related]
48. [Successful rituximab therapy for MALT lymphoma complicating cryoglobulinemic glomerulonephritis]. Akiyama K; Itabashi M; Shiohira S; Tsuruta Y; Shimizu A; Kamiyama M; Ishihara M; Otsubo S; Takei T; Taneda S; Honda K; Nitta K Nihon Jinzo Gakkai Shi; 2011; 53(5):713-8. PubMed ID: 21842606 [TBL] [Abstract][Full Text] [Related]
49. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. El-Hallak M; Binstadt BA; Leichtner AM; Bennett CM; Neufeld EJ; Fuhlbrigge RC; Zurakowski D; Sundel RP J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113 [TBL] [Abstract][Full Text] [Related]
50. The efficacy and safety of rituximab in refractory pemphigus: a review of case reports. Allen KJ; Wolverton SE J Drugs Dermatol; 2007 Sep; 6(9):883-9. PubMed ID: 17941359 [TBL] [Abstract][Full Text] [Related]
51. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Peters HP; van de Kar NC; Wetzels JF Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266 [TBL] [Abstract][Full Text] [Related]
52. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab]. Al-Ali HK; Wittekind C; Niederwieser D Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864 [TBL] [Abstract][Full Text] [Related]
53. Varicella infection in adult renal allograft recipients: experience at one center. Rodriguez-Moreno A; Sanchez-Fructuoso AI; Calvo N; Ridao N; Conesa J; Marques M; Prats D; Barrientos A Transplant Proc; 2006 Oct; 38(8):2416-8. PubMed ID: 17097954 [TBL] [Abstract][Full Text] [Related]
54. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris. Faurschou A; Gniadecki R Int J Dermatol; 2008 Mar; 47(3):292-4. PubMed ID: 18289336 [TBL] [Abstract][Full Text] [Related]
55. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases. Kerl K; Prins C; Saurat JH; French LE Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389 [TBL] [Abstract][Full Text] [Related]
56. Case of membranoproliferative glomerulonephritis due to essential cryoglobulinemia without hepatitis C virus infection. Okura T; Jotoku M; Miyoshi K; Enomoto D; Kurata M; Irita J; Nagao T; Ohtsuka T; Higaki J Geriatr Gerontol Int; 2009 Mar; 9(1):92-6. PubMed ID: 19260986 [TBL] [Abstract][Full Text] [Related]
57. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome. Grenda R; Jarmużek W; Rubik J; Piątosa B; Prokurat S Eur J Pediatr; 2016 Sep; 175(9):1133-1137. PubMed ID: 27364906 [TBL] [Abstract][Full Text] [Related]
58. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. Fabrizi F; Lunghi G; Messa P; Martin P J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865 [TBL] [Abstract][Full Text] [Related]
59. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932 [TBL] [Abstract][Full Text] [Related]
60. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]